Skip to main content

Table 3 Expression ratios of mRNA in the synovial membrane

From: Increased synovial immunohistochemistry reactivity of TGF-β1 in erosive peripheral psoriatic arthritis

mRNA*

All

n= 42

PsA

n = 15

RA

n = 8

OA

n = 15

AS

n = 4

p

DKK1

0.74

(0.33–2.52)

1.22

(0.36–6.41)

0.50

(0.37–2.19)

0.45

(0.20–0.84)

4.32

(0.97–12.23)

0.112

Sclerostin

0.0

(0.0-0.69)

0.0

(0.0-0.16)

0.58

(0.0-0.88)

0.0

(0.0-1.77)

0.0

(0.0-0.23)

0.504

BMP2

1.28

(0.59–1.72)

1.27

(0.73–1.43)

1.02

(0.52–1.54)

1.68

(1.43–2.28)

1.08

(0.37–1.78)

0.145

BMP4

1.07

(0.73–1.84)

1.17

(0.73–1.83)

0.90

(0.73–1.37)

2.01

(0.63–2.29)

1.06

(0.39–1.28)

0.339

Wnt1

0.44

(0.24–2.25)

1.44

(0.40–7.95)

0.30

(0.17–2.99)

0.27

(0.0-1.78)

0.60

(0.22–1.94)

0.191

Wnt5a

0.62

(0.40–1.25)

0.48

(0.33–1.43)

0.55

(0.47–1.10)

1.15

(0.48–2.30)

0.56

(0.35–0.81)

0.533

TGFβ1

0.99

(0.73–1.27)

0.92

(0.61–1.24)

0.99

(0.78–1.54)

1.01

(0.85–1.32)

1.05

(0.68–1.18)

0.921

IL6

0.90

(0.42–2.99)

1.85

(0.55–3.34)

0.73

(0.19–2.35)

0.58

(0.38–2.67)

1.74

(0.88–21.48)

0.371

IL17A

0.11

(0.0-1.34)

1.64

(0.30–2.25)

0.41

(0.10–0.70)

0.11

(0.00-0.05)

1.09

(0.00-5.31)

0.018

IL22

0.67

(0.0-1.79)

0.69

(0.12–2.10)

0.73

(0.10–2.20)

0.23

(0.00-0.71)

1.61

(0.49–5.55)

0.342

IL23

1.09

(0.41–2.27)

1.16

(0.68–2.33)

0.75

(0.32–1.91)

1.41

(0.54–2.25)

2.94

(2.41–4.85)

0.215

  1. *Data as median (Q1-Q3). Kruskal-Wallis test.